NovoCure Company
An Oncology Company Pioneering a Novel Therapy for Solid Tumors
Founded Date:
2000
Total Funding:
$152M
Investor Type:
Company
Employee Number:
200-500
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
Grant
Technology:
Others
Industry:
PharmTech
Headquarters:
Jersey, Arkansas, United States
Estimated Revenue:
$50M to $100M